Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 4 hrs 46 mins

S&P Futures
5,892.00
-28.00(-0.47%)
Dow Futures
43,306.00
-234.00(-0.54%)
Nasdaq Futures
20,534.50
-99.00(-0.48%)
Russell 2000 Futures
2,294.90
-22.80(-0.98%)
Crude Oil
68.59
-0.57(-0.82%)
Gold
2,636.80
+22.20(+0.85%)

HealthEquity, Inc. (HQY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

102.40

+3.42

(+3.46%)

At close: 04:00PM EST

102.40

0.00

(0.00%)

After hours:

04:42PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	8.94B
Enterprise Value	9.77B
Trailing P/E	82.48
Forward P/E	26.88
PEG Ratio (5 yr expected)	1.07
Price/Sales (ttm)	7.93
Price/Book (mrq)	4.01
Enterprise Value/Revenue	8.62
Enterprise Value/EBITDA	27.60

Trading Information

Stock Price History

Beta (5Y Monthly)	0.52
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	103.12
52 Week Low ³	62.10
50-Day Moving Average ³	85.02
200-Day Moving Average ³	80.92

Share Statistics

Avg Vol (3 month) ³	602.67k
Avg Vol (10 day) ³	920.64k
Shares Outstanding ⁵	87.32M
Implied Shares Outstanding ⁶	N/A
Float ⁸	85.83M
% Held by Insiders ¹	2.06%
% Held by Institutions ¹	103.64%
Shares Short (Oct 31, 2024) ⁴	4.19M
Short Ratio (Oct 31, 2024) ⁴	8.61
Short % of Float (Oct 31, 2024) ⁴	5.60%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	4.80%
Shares Short (prior month Sep 30, 2024) ⁴	4.29M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Jan 31, 2024
Most Recent Quarter (mrq)	Jul 31, 2024

Profitability

Profit Margin	9.61%
Operating Margin (ttm)	20.24%

Management Effectiveness

Return on Assets (ttm)	3.40%
Return on Equity (ttm)	5.15%

Income Statement

Revenue (ttm)	1.1B
Revenue Per Share (ttm)	12.73
Quarterly Revenue Growth (yoy)	23.10%
Gross Profit (ttm)	N/A
EBITDA	337.43M
Net Income Avi to Common (ttm)	105.67M
Diluted EPS (ttm)	1.20
Quarterly Earnings Growth (yoy)	238.60%

Balance Sheet

Total Cash (mrq)	326.89M
Total Cash Per Share (mrq)	3.74
Total Debt (mrq)	1.16B
Total Debt/Equity (mrq)	53.66
Current Ratio (mrq)	4.10
Book Value Per Share (mrq)	24.70

Cash Flow Statement

Operating Cash Flow (ttm)	307.74M
Levered Free Cash Flow (ttm)	-192.96M